Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Pediatric Upper and Lower Limb Spasticity: Results From 2 Open-Label, Long-term Extension Trials.
Gormley M, Fehlings D, Kim H, Bonikowski M, Banach M, Gul F, Meilahn J, Racette B, Huang N, Niu X, James LM, Dimitrova R. Gormley M, et al. Among authors: racette b. J Child Neurol. 2024 Dec 23:8830738241288431. doi: 10.1177/08830738241288431. Online ahead of print. J Child Neurol. 2024. PMID: 39716821
Olfactory tract/bulb metal concentration in Manganese-exposed mineworkers.
Gonzalez-Cuyar LF, Nelson G, Nielsen SS, Dlamini WW, Keyser-Gibson A, Keene CD, Paulsen M, Criswell SR, Senini N, Sheppard L, Samy S, Simpson CD, Baker MG, Racette BA. Gonzalez-Cuyar LF, et al. Among authors: racette ba. Neurotoxicology. 2024 May;102:96-105. doi: 10.1016/j.neuro.2024.04.001. Epub 2024 Apr 4. Neurotoxicology. 2024. PMID: 38582332
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study.
Reilmann R, Anderson KE, Feigin A, Tabrizi SJ, Leavitt BR, Stout JC, Piccini P, Schubert R, Loupe P, Wickenberg A, Borowsky B, Rynkowski G, Volkinshtein R, Li T, Savola JM, Hayden M, Gordon MF; LEGATO-HD Study Group. Reilmann R, et al. Lancet Neurol. 2024 Mar;23(3):243-255. doi: 10.1016/S1474-4422(23)00454-4. Epub 2024 Jan 24. Lancet Neurol. 2024. PMID: 38280392 Clinical Trial.
185 results